RecruitingPhase 2NCT06136403
A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses
Studying Epidermolysis bullosa simplex
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Principal Investigator
- Christine ChiaveriniCentre Hospitalier Universitaire de Nice
- Intervention
- deucravacitinib(drug)
- Enrollment
- 10 enrolled
- Eligibility
- 18-99 years · All sexes
- Timeline
- 2024 – 2026
Study locations (2)
- CHU de Nice, Nice, CHU de NICE, France
- APHP St Louis, Paris, France, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06136403 on ClinicalTrials.gov